MICALL2 and ovarian carcinoma: A previous study reported that, the stronger MICAL-L2 staining was detected in epithelial ovarian cancer (EOC) samples than that in the benign ovarian cysts, which was determined by IHC staining using a tissue microarray that contained 414 EOC tissue samples and 123 benign ovarian cysts [42].